Table 2.

Immunophenotypic features of cytotoxic PTCL-NOS based on the workshop cases and cases published in recent literature (Nicolae et al. and Wai et al.) [20, 16]

	Workshop cases	Nicolae et al. [20]	Wai et al. [16]
CD8	13/21 (62%)	28/54 (45%)	17/25 (68%)
TCRβF1	9/12 (75%)	17/36 (47%)	12/25 (48%)
AC phenotype	15/18 (83%)	45/54 (98%)	NA
TBX21 phenotype	7/9 (78%)	36/38 (95%)	NA
CD30 positive	7/18 (39%)	36/53 (68%)	NA
CD56 positive	4/21 (19%)	4/44 (9%)	6/24 (25%)

AC activated cytotoxic, NA not available